Asthma Clinical Trial
Official title:
Impact of Aerobic Exercise on Asthma Morbidity
Asthma is a chronic disorder of the airways primarily driven by increased airway inflammation, and is an escalating medical problem in Canada. For example, between 1994 and 2001 there was a 40% increase in the number of Canadians who had asthma. Not only is the prevalence of asthma increasing but there has been a rapid rise in the number of asthma events and costs associated with asthma and poor asthma control. It has been estimated that the global cost of caring for asthma exceeds that of AIDS/HIV and tuberculosis combined. These increases have occurred in spite of the development of clear asthma management guidelines. There is evidence to suggest that aerobic exercise, e.g., running or cycling, may improve asthma symptoms and control in children. However, there are currently no studies that have systematically assessed the effects of exercise on asthma control or symptoms in adults. The current proposed study will assess the effects of aerobic exercise in sedentary patients with poorly controlled asthma. In addition to usual medical care, 52 patients will participate in a supervised aerobic exercise program. The program will consist of 3 X 1hr sessions of supervised exercise per week for 12 weeks. Another 52 patients will only maintain usual medical care. The asthma control, quality of life, and inflammatory profile will be evaluated at baseline and following the 12 weeks of treatment. The investigators believe that: (1) The exercise intervention will significant improve asthma control and asthma quality of life; (2) The exercise intervention will result in significant improvements in inflammatory profiles; and (3) These changes in the inflammatory profile will be directly related to the improvements in asthma control and quality of life.
Introduction: Asthma is a chronic respiratory disorder primarily driven by increased airway
inflammation. It is one of the most prevalent chronic conditions affecting Canadians. It is
the most common chronic illness affecting children and the fourth most common disorders
affecting adults. In 2001, nearly 2.2 million (8.4%) Canadians were diagnosed as having
asthma. More importantly, asthma is an escalating medical problem in Canada, e.g., between
1994 and 2001, there was a 40% increase in the number of Canadians with asthma. Not only is
the prevalence of asthma increasing, but there has been a rapid rise in the morbidity and
costs associated with asthma and its poor control. The WHO estimated that the global cost of
caring for asthma exceeds that of AIDS/HIV and tuberculosis combined. Though recent
guidelines have emphasized the importance of improving asthma control and quality of life,
leading to huge amounts of resource being dedicated to this, more than 50% of adult patients
with asthma remain poorly controlled. As current treatment strategies appear to be failing,
it is important to target simple, cost effective interventions that are applicable for most
patients with asthma and will increase overall levels of control and decrease asthma
morbidity. There is evidence to suggest that aerobic exercise may improve asthma symptoms and
control in children. In addition, there is evidence that exercise directly improves
inflammatory and immune profiles in non-asthma patients, which may provide the mechanism by
which exercise could improve asthma. However, there are no known studies that have
systematically assessed the effects of aerobic exercise on asthma control, quality of life or
immune function in adult asthma populations.
Objective: The primary objective of the current application is to assess the efficacy of
aerobic exercise as an intervention to improve asthma control and quality of life in adult
patients with asthma. The results of this study will provide data that will inform physicians
and members of the Thoracic community about the benefits of exercise for asthma. The study
will also assess potential inflammatory pathways by which exercise may elicit improvements in
asthma morbidity. The results of this study should be available for the next Canadian
Thoracic Society Canadian Adult Consensus Guidelines.
Methodology: The current proposal is for a study of aerobic exercise in sedentary patients
with poorly controlled asthma. In addition to usual care, 52 patients will undertake
supervised aerobic exercise. The exercise program will consist of 3 X 1hr sessions of
supervised exercise per week for 12 weeks. The exercise routine, under medical supervision,
will consist of 10 minutes of warm up exercises, 40 minutes of biking and/or walking (and
eventually jogging), and 10 minutes of cool down exercises. These patients will be compared
to a group of 52 patients who will follow their usual regimen, this group will be offered the
exercise programme once they have completed the post assessments. For the primary outcomes
(asthma control [Asthma Control Questionnaire], quality of life [Asthma Quality of Life
Questionnaire]) and secondary outcomes (inflammatory profile) will be evaluated at baseline
and after 12 weeks (the length of the treatment). To check the efficacy of the intervention
both lung function, ambulatory peak flow, and exercise tolerance data will also be collected.
Repeated measures analysis of covariance-type models with time (pre, post intervention) as
the within subject factor, group (exercise, usual care) as the between factor, and sex, age,
and asthma severity as the covariates will be used for the primary outcome variables. To
assess the potential mechanistic role of inflammation on the exercise-asthma relationship a
series of regression-like GLMs will be conducted.
It is hypothesized that: (1) The exercise intervention will result in clinically and
statistically significant improvements in levels of asthma control and asthma quality of
life; (2) The exercise intervention will result in clinically and statistically significant
improvements in inflammatory profiles, with reductions in Th2 cytokines, and activation of
inflammatory cells, and increases in Th1 cytokines; and (3) Changes in inflammatory profile
will be directly linked to improvements in asthma measures.
We believe that the proposal will have great clinical significance for patient management.
This project will be the first to systematically evaluate the benefits of exercise training
on asthma control and quality of life in adult asthma patients. We anticipate that the
results of this study will form the basis for new national and international guidelines and
will provide an evidence-based background for physicians to prescribe aerobic exercise for
patients with asthma.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|